Bilibili Inc. Stock Prediction and Forecast [BILI]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 03 Dec 2025, 20:30 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Bilibili Inc. Stock Prediction and Forecast [BILI]](https://i.ytimg.com/vi/-iGBbmP8el0/hqdefault.jpg)
AI-generated source summary
The analysis focuses on BILI stock. Since December 1st, 2025, BILI has been a hold or accumulate, a score of -0.080. Currently sits low broad short-term upward trend, offering a buying opportunity. Floor is $24.38; breaching signifies decrease rate. The analysts said over 3 months expecting 6.38% fluctuation, with returns fluctuating from 0.443% to 34.92%. The overall analysis expects 50.11% shift over the year with fluctuating potential returns of 28.75% to 92.13%, positioning price from $33.24 and $49.61. The Last day for the stock down is $25.82 -2.71%. There will be levels of support and resistance at $25.89 the high and at $25.45 low. Long and short moving averages have cell signals, so do some correction up with certain resistance at $26.24 and $27.68.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.